Takeda Breathes New Life Into Entyvio With Preventative Use In Crohn’s Disease

Takeda’s head of gastroenterology talked to In Vivo about the major’s plans for finding biomarkers for Crohn’s disease as part of a Euro-wide prevention and interception trial.

More from Market Access

More from Leadership